MENU
BCRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioCryst Pharmaceuticals (BCRX) Earnings Date & Reports

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

BCRX is expected to report earnings to fall 43.85% to -7 cents per share on May 01

BioCryst Pharmaceuticals BCRX Stock Earnings Reports
Q1'25
Est.
$-0.07
Q4'24
Missed
by $0.06
Q3'24
Est.
$-0.07
Q2'24
Beat
by $0.11
Q1'24
Beat
by $0.04
The last earnings report on February 24 showed earnings per share of -12 cents, missing the estimate of -7 cents. With 1.93M shares outstanding, the current market capitalization sits at 1.55B.
View a ticker or compare two or three
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of small molecule pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4505 Emperor Boulevard
Phone
+1 919 859-1302
Employees
536
Web
https://www.biocryst.com